专栏药物

Joinn Labs undermined by AI as FDA phases out animal drug testing
美国淘汰动物测试,昭衍新药前景受压

The outsourced clinical research services provider’s shares tumbled after the U.S. drug regulator announced a new approach to drug testing.
在美国药品监管机构宣布药物实验新规后,这家提供外包临床研究服务的公司股价应声暴跌。

Much is written about all the benefits that AI will bring, including greatly boosting the efficiency of new drug discovery in the pharmaceutical sector. But far less is written about industries likely to become victims of AI’s success, making their current business models obsolete.

关于人工智能带来的好处,包括大幅提升制药行业的新药研发效率,已经有很多文章进行了阐述。但关于哪些行业可能会成为人工智能的牺牲品,令其商业模式被淘汰,却鲜有报道。

您已阅读5%(362字),剩余95%(7408字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×